Clinical Trial Update: A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2, single-arm trial evaluating the combination of carboplatin and gemcitabine with BSI-201 in platinum-resistant recurrent ovarian cancer. The study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• BSI-201 (iniparib)
• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Sanofi | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED